用智能手机应用程序减轻抑郁症状:一项随机安慰剂对照试验的研究方案
该研究方案针对有中度抑郁症状的罗马尼亚语成年人群,开展一项三臂随机对照试验,比较基于认知行为疗法(CBT)的智能手机应用程序与主动安慰剂及延迟干预的效果。计划纳入220名参与者,主要结局为抑郁症状水平,旨在检验该应用程序相较于主动安慰剂的临床有效性。
要点
- 研究采用三臂随机设计:活性干预、安慰剂干预和延迟干预。
- 纳入标准为PHQ-9评分>9且≤16的中度抑郁症状成人。
- 活性与安慰剂组使用应用程序6周,每周接受电话治疗师简短核查。
核心结论
- 该研究方案旨在检验一款基于CBT理论的智能手机应用程序相较于主动安慰剂在减轻中度抑郁症状方面的临床有效性。
研究设计与样本
- 一项随机、三臂临床试验,比较活性干预、安慰剂干预和延迟干预。
- 计划纳入220名有中度抑郁症状(PHQ-9评分>9且≤16)的罗马尼亚语成年参与者。
- 参与者需拥有电脑、互联网和智能手机,排除正在接受治疗、有严重心理健康问题、法律或健康问题妨碍使用应用程序以及有自杀意念者。
主要发现
- 原文未报告结果,因为本文为研究方案。
关键数值与推荐
- 主要结局为抑郁症状水平。
- 活性干预组应用程序包含基于CBT的抑郁心理教育材料和练习,安慰剂干预组使用结构相似的假版本应用程序。
- 活性与安慰剂组使用应用程序6周,每周接受电话治疗师简短核查;延迟干预组在随机化6周后获得应用程序访问权限。
临床怎么用
- 原文未报告临床实践推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Depression has become one of the leading contributors to the global disease burden. Evidence-based treatments for depression are available, but access to them is still limited in some instances. As technology has become more integrated into mental health care, computerized cognitive behavioral therapy (CBT) protocols have become available and have been recently transposed to mobile environments (e.g., smartphones) in the form of "apps." Preliminary research on some depression apps has shown promising results in reducing subthreshold or mild to moderate depressive symptoms. However, this small number of studies reports a low statistical power and they have not yet been replicated. Moreover, none of them included an active placebo comparison group. This is problematic, as a "digital placebo effect" may explain some of the positive effects documented until now. The aim of this study is to test a newly developed mobile app firmly grounded in the CBT theory of depression to determine whether this app is clinically useful in decreasing moderate depressive symptoms when compared with an active placebo. Additionally, we are interested in the app's effect on emotional wellbeing and depressogenic cognitions. METHODS/DESIGN: Romanian-speaking adults (18 years and older) with access to a computer and the Internet and owning a smartphone are included in the study. A randomized, three-arm clinical trial is being conducted (i.e., active intervention, placebo intervention and delayed intervention). Two hundred and twenty participants with moderate depressive symptoms (i.e., obtaining scores >9 and ≤16 on the Patient Health Questionnaire, PHQ-9) will be randomized to the three conditions. Participants undergoing therapy, presenting serious mental health problems, or legal or health issues that would prevent them from using the app, as well as participants reporting suicidal ideation are excluded. Participants randomized to the active and placebo interventions will use the smartphone app for 6 weeks. A short therapist check-in via phone will take place every week. Participants in the delayed-intervention condition will be given access to the app after 6 weeks from randomization. The primary outcome is the level of depressive symptomatology. The intervention delivered through the app to the active condition includes psychoeducational materials and exercises based on CBT for depression, while the placebo intervention uses a sham version of the app (i.e., similar structure of courses and exercises). DISCUSSION: To our knowledge, this study protocol is the first to test the efficacy of a smartphone app for depressive symptomatology in the form of a randomized controlled trial (RCT) that includes an active placebo condition. As such, this can substantially add to the body of evidence supporting the use of apps designed to decrease depression. TRIAL REGISTRATION: ClinicalTrials.gov, identifier: NCT03060200 . Registered on 1 February 2017. The first participant was enrolled on 17 February 2017.
引用
- Giosan C, Cobeanu O, Mogoaşe C, et al. Reducing depressive symptomatology with a smartphone app: study protocol for a randomized, placebo-controlled trial. Trials. 2017. PMID: 28494802. doi:10.1186/s13063-017-1960-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。